Science Current Events | Science News | Brightsurf.com
 

Cell skeleton may hold key to overcoming drug resistance in cancer

October 04, 2007
Researchers have uncovered a new way in which a cell protein protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients.

A team of scientists at Children's Cancer Institute Australia for Medical Research (CCIA), led by Associate Professor Maria Kavallaris, discovered that the bIII-tubulin component of the cell's cytoskeleton could play an important role in resistance to a wide range of drugs used to treat lung, ovarian and breast cancers.

Advanced non-small cell lung carcinomas (NSCLC) account for more than 80 per cent of lung cancer cases. More than one million people are diagnosed with lung cancer every year, the most common cancer in the world and the leading cause of cancer deaths. Chemotherapy remains the most effective treatment option, involving a diverse range of drugs, often used in combination. However, the emergence of drug-resistant tumours in NSCLC means chemotherapy no longer holds the promise of a good outcome for many patients.

Increased expression of bIII-tubulin has been linked to drug resistance in NSCLC, ovarian and breast cancers. In the latest Cancer Research publication, Associate Professor Kavallaris and her team showed that blocking the expression of the bIII-tubulin gene in NSCLC cells led to an increase in their sensitivity to a range of chemotherapeutic drugs.

"Our results strongly suggest that the bIII-tubulin component is responsible for protecting NSCLC cells from the action of key chemotherapeutic drugs," said Associate Professor Kavallaris.

"This is the first scientific evidence for the broader implications of abnormal expression of this protein.

"We now have new insight into a mechanism of drug resistance in NSCLC which has not previously been reported. This has important implications for improving the targeting and treatment of a number of cancers which are resistant to current chemotherapeutic drugs," said Associate Professor Kavallaris.

Research Australia


Related Chemotherapeutic Drug Current Events and Chemotherapeutic Drug News Articles


Innovative light therapy reaches deep tumors
Light long has been used to treat cancer. But phototherapy is only effective where light easily can reach, limiting its use to cancers of the skin and in areas accessible with an endoscope, such as the gastrointestinal tract.

CNIO associates rare gene variants with side effects from chemotherapy with paclitaxel
Paclitaxel is a chemotherapeutic drug that has been shown to be highly effective when treating solid tumours, such as breast, ovarian and lung tumours.

Major discovery on the mechanism of drug resistance in leukemia and other cancers
A mechanism that enables the development of resistance to Acute Myeloid Leukemia (AML) anticancer drugs, thereby leading to relapse, has been identified by Kathy Borden of the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) and her collaborators.

Genetic aberration paves the way for new treatment of cancer disease
Researchers from Faculty of Health and Medical Sciences, University of Copenhagen, have characterized a genetic aberration on a group of colorectal cancer patients.

Nanotech system, cellular heating may improve treatment of ovarian cancer
The combination of heat, chemotherapeutic drugs and an innovative delivery system based on nanotechnology may significantly improve the treatment of ovarian cancer while reducing side effects from toxic drugs, researchers at Oregon State University report in a new study.

Celery, artichokes contain flavonoids that kill human pancreatic cancer cells
Celery, artichokes, and herbs, especially Mexican oregano, all contain apigenin and luteolin, flavonoids that kill human pancreatic cancer cells in the lab by inhibiting an important enzyme, according to two new University of Illinois studies.

More Effective Immunotherapy for Melanoma Hinges on Blocking Suppressive Factors, Moffitt Cancer Center Researchers Say
Researchers at the Moffitt Cancer Center have found that delayed tumor growth and enhanced survival of mice bearing melanoma were possible by blocking the reconstitution of myeloid-derived suppressor cells and Tregs (suppressors of anti-tumor activity) after total body irradiation had eliminated them.

CWRU School of Medicine researchers discover gene that permanently stops cancer cell proliferation
Researchers at Case Western Reserve University School of Medicine have discovered a mutant form of the gene, Chk1, that when expressed in cancer cells, permanently stopped their proliferation and caused cell death without the addition of any chemotherapeutic drugs.

Regulation by proteins outside cancer cells points to potential new drug target
Protein interactions outside breast cancer cells can send signals to the cancer cells to permanently stop proliferating, a new study showed in the School of Medicine at The University of Texas Health Science Center San Antonio.

Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
Researchers from the University of Notre Dame have engineered nanoparticles that show great promise for the treatment of multiple myeloma (MM), an incurable cancer of the plasma cells in bone marrow.
More Chemotherapeutic Drug Current Events and Chemotherapeutic Drug News Articles

2015 Oncology Nursing Drug Handbook

2015 Oncology Nursing Drug Handbook
by Gail M. Wilkes (Author), Margaret Barton-Burke (Author)


Written especially for nurses caring for patients with cancer, the 2015 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2015 Oncology Nursing Drug Handbook includes a simplified chapter on molecular and biological targeted therapy that incorporates new information about immunotherapy, new indications, and the most important and common side effects. New drug entries include: afatinib, belinostat, ceritinib, ibrutinib, idelalisib,...

Litt's Drug Eruption and Reaction Manual, 21st Edition

Litt's Drug Eruption and Reaction Manual, 21st Edition
by Jerome Z. Litt (Author)


Internationally relied upon by medical practitioners for its unparalleled focus on adverse effects and cutaneous reactions, this succinct clinical reference is the essential drug-safety tool for patient care. The book provides complete coverage of the reaction profiles of numerous prescription and over-the-counter drugs and supplements and includes convenient lists of classes of drugs known to cause reactions. This 21st edition has been comprehensively revised and updated, featuring an enlarged section of tables for class reactions and new entries for recently licensed drugs.

Physicians' Cancer Chemotherapy Drug Manual 2015

Physicians' Cancer Chemotherapy Drug Manual 2015
by Edward Chu (Author), Vincent T. DeVita Jr. (Author)


Completely revised and updated for 2015, the Physicians’ Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens―both on- and off-label―for the treatment of all the major cancers. SPECIAL FEATURES: • Revised to reflect rapid advances in the field, incorporating treatment strategies and new drugs like afatinib, ceritinib, ibrutinib, idelalisib, obinutuzumab, and ramucirumab. • A specific chapter focused on profiling antiemetic drugs and antiemetic treatment regimens. • Diagrams of drug structures and pathways for many of...

Disease & Drug Consult: Respiratory Disorders

Disease & Drug Consult: Respiratory Disorders
by Lippincott (Author)


Disease & Drug Consult is a unique new series of handbooks that combine disease monographs plus monographs on drugs used to treat diseases. Each Disease & Drug Consult book focuses on a specific body system and has two sections. Part 1 presents diseases alphabetically, with a description, causes & incidence, signs & symptoms, complications, diagnosis, treatment including drugs used to treat the disease and the reason for using each drug, and special considerations. Part 2, also organized alphabetically, offers complete drug monographs for each drug mentioned in the disease section. In the Respiratory Disorders volume, for example, the nurse can read a full description of asthma, then turn to the drug monographs for a full discussion of each of the drugs used to treat that...

Litt's D.E.R.M. Drug Eruptions and Reactions Manual, 20th Edition (Drug Eruption Reference Manual)

Litt's D.E.R.M. Drug Eruptions and Reactions Manual, 20th Edition (Drug Eruption Reference Manual)
by Jerome Z. Litt (Author)


Relied upon by dermatologists and medical practitioners internationally for its unparalleled practical focus on adverse effects and cutaneous reactions, this text is the essential quick-reference tool for patient care and drug safety. The reaction data for this new 20th edition is compiled from the companion website, which is updated continuously, and includes prescription and over-the-counter drugs as well as biologics, supplements, and other medical products—with tens of thousands of adverse drug reactions, eruptions, and reaction patterns. The text notes the number of peer-reviewed references for reaction listings, the reported incidence of a reaction, and clinically important and potentially serious interactions between drugs.

Pharmacotherapy Flash Cards

Pharmacotherapy Flash Cards
by Jeremy Johnson (Author), Michelle Condren (Author), Kimberly Crosby (Author), Ann Lloyd (Author), Kelly Murray (Author)


238 Q&A cards sharpen your therapeutic decision-making skills "These cards offer concise yet detailed case studies for students to review current pharmacotherapeutic options for many of the commonly encountered disease states....Students might find these cards to be a very helpful in addition to their therapeutics courses to help them retain knowledge through the use of real-life clinical scenarios. 3 Stars."--Doody's Review Service
These 238 Q&A cards provide a complete review of pharmacotherapeutic concepts for the major disease states most often encountered in practice Emphasizes evidence-based therapeutic decision making and drug therapy monitoring Each card features a case and therapeutic question Key facts are included for the drug or drug class that correctly answers the...

Basic and Clinical Pharmacology 13 E

Basic and Clinical Pharmacology 13 E
by Bertram Katzung (Author), Anthony Trevor (Author)


Gain a full understanding of the basic science and clinical use of drugs with the most up-to-date and comprehensive pharmacology text in the health sciences 400 ILLUSTRATIONS--MANY IN FULL COLOR Organized to reflect the course sequence in many pharmacology courses and in integrated curricula, Basic & Clinical Pharmacology covers the important concepts students need to know about the science of pharmacology and its application to clinical practice. Selection of the subject matter and order of its presentation are based on the authors' many years of experience in teaching this material to thousands of medical, pharmacy, dental, podiatry, nursing, and other health science students. Coverage that spans every aspect of medical pharmacology: Encompasses every aspect of medical pharmacology...

Natural Alternatives (o T C) to Over-The-counter and Prescription Drugs

Natural Alternatives (o T C) to Over-The-counter and Prescription Drugs
by Michael T. Murray (Author)


Is there really a safer, more effective natural alternative to most prescription and over-the-counter medicines? Yes. In Natural Alternatives to Over-the-Counter and Prescription Drugs, his groundbreaking book, naturopathic physician Michael T. Murray provides specific natural alternatives to some of the drugs most used by Americans, including Tagamet, Prednisone, Seldane, and Zantac. Examining the side effects and effectiveness of many of the drugs used today, Murray shows how these drugs can be replaced with less expensive natural remedies whose medicinal benefits have been proven in clinical studies. He discusses how herbs, vitamins, minerals, extracts, and ointments can be used to bring relief from a wide array of specific ailments, including:Diabetes Asthma, hay fever, and the...

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)
by Benjamin Bonavida (Editor)


This book reviews novel approaches developed to reverse tumor cell resistance to chemo/immuno/radio-therapy and the use of various sensitizing agents in combination with various cytotoxics. It also introduces several current approaches developed by established investigators that are aimed at overcoming resistance. This is the first volume to compile studies on tumor cell sensitization. It will prove useful for students, scientists, clinicians and pharmaceutical companies.

Cancer Chemotherapeutic Agents (Acs Professional Reference Book)

Cancer Chemotherapeutic Agents (Acs Professional Reference Book)
by William O. Foye (Editor)


An authoritative treatment of the discovery, development, and understanding of cancer chemotherapeutic agents. Addresses the major classes of chemotherapeutic agents, including antimetabolites, agents that react with DNA, inhibitors of transcription enzymes, topoisomerase inhibitors, DNA minor-groove binding compounds, antimotic agents, bleomycin group antitumor antibiotics, antihormones, paclitaxels, and photochemically activated agents. Provides an overview of the various classes of agents now considered important. Examines a method for determining the similarity of mechanism of the compounds in a given class.

© 2015 BrightSurf.com